LBPH Longboard Pharmaceuticals, Inc. Kompaniyaning sof foydasi

longboardpharma.com (LBPH) kompaniyasining rasmiy ramzlari

Longboard Pharmaceuticals (LBPH) kompaniyasining GURU.Markets grafik chizig'idagi foydasi, bunda -0.08 ushbu parametrning qiymatini ko'rsatadi, kompaniyaning Bexicaserin sinovlariga va tartibga soluvchi organlarning tasdiqlashlariga bog'liqligini ta'kidlaydi. Lundbeck bilan tuzilgan kelishuv moliyaviy defitsitni bartaraf etdi va yakuniy sinovlar uchun barqaror sur'atni ta'minladi. Shu bilan birga, Longboard Pharmaceuticals (LBPH) kam uchraydigan nevrologik patologiyalar uchun davolash tizimini ishlab chiqmoqda va epilepsiya bilan kasallangan bolalar uchun parvarishning yangi standartlarini joriy qilmoqda.

Kompaniyaning sof foydasi: longboardpharma.com (LBPH) 04.07.2022 - 07.12.2024 uchun

Longboard Pharmaceuticals, Inc. (LBPH) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Longboard|LBPH - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Longboard|LBPH - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Longboard Pharmaceuticals|LBPH - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati longboardpharma.com|LBPH - Kompaniyaning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning kapitalga nisbati Longboard Pharmaceuticals|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Longboard Pharmaceuticals Inc|LBPH - Kompaniya qarzlari|Balans qiymatiga qarzlar Longboard|LBPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Longboard Pharmaceuticals|Oraliq qoplash koeffitsiyenti longboardpharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
LBPH - Sof foyda
Kompaniyaning asosiy tahlili:LBPH Longboard
Longboard Pharmaceuticals Inc original mahsuloti

Longboard Pharmaceuticals (LBPH) kompaniyasining noyob nevrologik kasalliklar terapiyasi segmentidagi shiddatli rivojlanishi tadqiqot va ishlanmalar (R&D) xarajatlarining samaradorligini aniq monitoring qilishni talab etadi. Kompaniyaning foyda darajalarini tahlil qilish real moliyaviy muvaffaqiyatni likvidlilik xatarlaridan ajratgan holda, haqiqiy operatsion daromadliligini tekshirish imkonini beradi, bu esa shiddatli bozor raqobati sharoitida investorlar kapitalining barqarorligini baholash uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniyaning sof foydasi RGC|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|VKTX: Kompaniya foydasi|Supernus Pharmaceuticals - Sof foyda|Yillik sof foyda catalystpharma.com (CPRX)|DNLI: Sof foyda|HRMY (Harmony Biosciences Inc) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Kompaniyaning sof daromadi Amylyx Corp AMLX|Sof foyda TRVI|Sof foyda praxismedicines.com (PRAX)|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|Yakuniy foyda CBLL|Prothena Biosciences - Sof foyda|ALEC (Alector, Inc.) - Kompaniya foydasi|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|Kompaniyaning sof foydasi Neurogene|AC Immune S.A. - Soliqdan keyingi foyda|Sof foyda VYGR|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|Sof foyda tevogen.com TVGN|ACOG - Kompaniyaning sof foydasi|Yakuniy foyda CGTX (cogrx.com)|Inhibikase (IKT) - Kompaniyaning sof foydasi|Sof daromad Cassava Pharma|ASRT (Assertio Holdings) - Sof foyda|Sof foyda Coya|Sof foyda VTGN|Sof daromad ovidrx.com OVID|Sof foyda ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Kompaniyaning sof daromadi|ATHE: Sof daromad|CLNN - Sof foyda|PEPG (pepgen.com) - Sof daromad|JUNS: Soliqlar to‘langandan keyingi foyda|RLMD (Relmada) - Sof foyda|Annovis Bio Corporation (ANVS) - Sof moliyaviy natija|Sof foyda GRCE|Sof daromad fireflyneuro.com AIFF|Sof foyda KLTO (Klotho Neurosciences)|Sof foyda NeuroSense Therapeutics Ltd NRSN|RVPH - Kompaniyaning sof foydasi|MTVA: Kompaniyaning sof foydasi|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|HSDT - Sof moliyaviy natija|Kompaniyaning sof foydasi Passage Bio Inc.|Kompaniyaning sof foydasi NEUP|Sof foyda NERV|Kompaniyaning sof foydasi ATHA (Athira Pharma Corp)|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN (Alzamend Neuro Inc.) - Soliqdan keyingi foyda|Cyclerion - Sof foyda|Yakuniy foyda PTIX (Protagenic Therapeutics)|pasitheaclinics.com (KTTA) - Kompaniyaning sof foydasi|Kompaniya foydasi CRGT|ATXI (Avenue Therapeutics) - Sof foyda|Kompaniyaning sof daromadi brainstorm-cell.com BCLI|Sof daromad CARA (Cara Therapeutics)|Sof foyda Chromocell Therapeutics Corp (CHRO)|Kompaniyaning sof foydasi Eliem Therapeutics Inc. ELYM|Yakuniy foyda ITCI|MRNS - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|SAGE (Sage Therapeutics Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Anew Medical Inc. - Kompaniya foydasi|Sof foyda CERE (Cerevel Therapeutics, Inc.)